NewAmsterdam’s experimental cholesterol drug reduces presence of Alzheimer’s biomarkernews2025-06-09T14:59:15+00:00June 9th, 2025|Endpoints News|
Metsera shares early data on anti-obesity amylin candidatenews2025-06-09T11:00:52+00:00June 9th, 2025|Endpoints News|
Is there still hope for Summit’s cancer drug buried in the data?news2025-06-06T15:21:09+00:00June 6th, 2025|Endpoints News|
Otsuka details positive Phase 3 IgAN data as it awaits FDA decisionnews2025-06-06T11:19:07+00:00June 6th, 2025|Endpoints News|
Generics giant Teva turns to branded drugs R&D for its futurenews2025-06-05T17:47:42+00:00June 5th, 2025|Endpoints News|
Corcept plots future for ALS drug that flunked Phase 2, citing survival analysisnews2025-06-05T15:22:14+00:00June 5th, 2025|Endpoints News|
Regenxbio reports Duchenne gene therapy data from five patientsnews2025-06-05T14:35:07+00:00June 5th, 2025|Endpoints News|
After layoffs, Casma eyes path to clinic with autophagy-boosting drugnews2025-06-04T19:24:35+00:00June 4th, 2025|Endpoints News|
Sagimet touts China partner Ascletis’ Phase 3 FASN inhibitor data in acnenews2025-06-04T15:44:00+00:00June 4th, 2025|Endpoints News|
AnaptysBio describes ‘JAK-like’ efficacy for PD-1 drug in rheumatoid arthritisnews2025-06-04T15:22:28+00:00June 4th, 2025|Endpoints News|
